National Endoscopy Quality Improvement Program Remains Suboptimal in Korea
Gut and Liver
;
: 699-705, 2016.
Article
in English
| WPRIM
| ID: wpr-166359
ABSTRACT
BACKGROUND/AIMS:
We evaluated the characteristics of the National Cancer Screening Program (NCSP) and opinions regarding the National Endoscopy Quality Improvement Program (NEQIP).METHODS:
We surveyed physicians performing esophagogastroduodenoscopy and/or colonoscopy screenings as part of the NCSP via e-mail between July and August in 2015. The 32-item survey instrument included endoscopic capacity, sedation, and reprocessing of endoscopes as well as opinions regarding the NEQIP.RESULTS:
A total of 507 respondents were analyzed after the exclusion of 40 incomplete answers. Under the current capacity of the NCSP, the typical waiting time for screening endoscopy was less than 4 weeks in more than 90% of endoscopy units. Performance of endoscopy reprocessing was suboptimal, with 28% of respondents using unapproved disinfectants or not knowing the main ingredient of their disinfectants and 15% to 17% of respondents not following reprocessing protocols. Agreement with the NEQIP was optimal, because only 5.7% of respondents did not agree with NEQIP; however, familiarity with the NEQIP was suboptimal, because only 37.3% of respondents were familiar with the NEQIP criteria.CONCLUSIONS:
The NEQ-IP remains suboptimal in Korea. Given the suboptimal performance of endoscopy reprocessing and low familiarity with the NEQIP, improved quality in endoscopy reprocessing and better understanding of the NEQIP should be emphasized in Korea.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Stomach Neoplasms
/
Colorectal Neoplasms
/
Mass Screening
/
Surveys and Questionnaires
/
Endoscopy, Digestive System
/
Colonoscopy
/
Endoscopes
/
Recognition, Psychology
/
Electronic Mail
/
Disinfectants
Type of study:
Diagnostic study
/
Prognostic study
/
Screening study
Country/Region as subject:
Asia
Language:
English
Journal:
Gut and Liver
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS